Afuco™ Anti-SLC34A2 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H45)

CAT#: AFC-TAB-H45

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human antibody to Human SLC34A2.

Gene Expression
Figure 1 IF staining of human cell line RPTEC TERT1 Figure 2 IF staining of human cell line RPTEC TERT1 Figure 3 High expression in lung Figure 4 RNA cell line category: Group enriched (BEWO, EFO-21, RPTEC TERT1)

Specifications

  • Host Species
  • Human
  • Derivation
  • human
  • Type
  • ADCC enhanced antibody
  • Specificity
  • SLC34A2 (solute carrier family 34 sodium phosphate member 2, sodium/phosphate cotransporter 2B, NaPi2b, NaPi3b, NAPI-3B) [Homo sapiens]
  • Species Reactivity
  • Human
  • Applications
  • ELISA, FC, IP, FuncS, IF, Neut
  • Conjugate
  • Unconjugated
  • Generic Name
  • Lifastuzumab
  • Related Disease
  • Ovarian cancers

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • SLC34A2; solute carrier family 34 (type II sodium/phosphate contransporter), member 2; NPTIIb; NAPI-3B; NAPI-IIb; sodium-dependent phosphate transport protein 2B; sodium/phosphate cotransporter 2B
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-H45. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
A Catalytic Tool for Oncological Research
As a catalytic tool in oncological research, this antibody facilitates a deeper understanding of phosphate transporter roles in cancer progression, making it invaluable for our ongoing studies in metabolic disorder analysis.
Breast cancer biomarkers at key points during disease progression
Promising for Targeted Cancer Therapy
Its specificity to SLC34A2 has been instrumental in highlighting promising approaches in targeted cancer therapies. By exploring its use in enhanced ADCC, we're opening pathways to more selective and effective treatments.
Breast cancer biomarkers at key points during disease progression
Perfect for Longitudinal Studies
Perfect for longitudinal studies, the antibody's high repeatability ensures consistency across numerous experiments, supporting extended research needs and facilitating comprehensive cancer studies.

Q&As

  1. What is the primary use of the Afuco™ Anti-SLC34A2 ADCC Recombinant Antibody

    A: This recombinant antibody is used primarily in oncology research to target the SLC34A2 protein, which is implicated in ovarian cancers. Its applications in ELISA, Flow Cytometry (FC), Immunoprecipitation (IP), Functional Studies (FuncS), Immunofluorescence (IF), and neutralization assays make it a key tool in understanding tumor biology and developing targeted therapies.

  2. How does this antibody enhance ADCC in cancer research?

    A: The antibody has been engineered for enhanced antibody-dependent cellular cytotoxicity (ADCC), increasing its ability to recruit immune cells to kill cancer cells expressing SLC34A2. This improvement makes it valuable in studying therapeutic pathways and developing antibody-mediated treatments that harness the body's immune system.

  3. How does this antibody facilitate the study of sodium/phosphate cotransporters?

    A: Targeting SLC34A2, a key sodium/phosphate cotransporter, this antibody helps elucidate its role in metabolic pathways and cancer. It supports research aiming to understand how disrupting transporter activity could be leveraged for therapeutic ends.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "SLC34A2"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
TAB-H45 Human Anti-SLC34A2 Recombinant Antibody (TAB-H45) ELISA, FC, IP, FuncS, IF, Neut, ICC Human IgG1, κ
CAT Product Name Application Type
VS-0425-FY167 Human Anti-SLC34A2 scFv-Fc Chimera (VS-0425-FY167) IHC Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC70 Recombinant Anti-SLC34A2 Vesicular Antibody, EV Displayed (VS-0425-YC70) ELISA, FC, Neut, Cell-uptake
CAT Product Name Application Type
VS-0525-XY6677 Anti-SLC34A2 Immunohistochemistry Kit IHC
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare